Article info
PDFBMJ Quality Improvement Report
Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
- Correspondence to Dr Joel Ward; joel.ward{at}nhs.net
Citation
Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
Publication history
- Received September 28, 2017
- Revised December 19, 2017
- Accepted December 30, 2017
- First published March 6, 2018.
Online issue publication
April 14, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/